Zacks: Xtant Medical Holdings Inc (XTNT) Given Consensus Recommendation of “Strong Buy” by Analysts
Shares of Xtant Medical Holdings Inc (NASDAQ:XTNT) have earned an average broker rating score of 1.00 (Strong Buy) from the three analysts that provide coverage for the stock, Zacks Investment Research reports. Three investment analysts have rated the stock with a strong buy recommendation.
Analysts have set a 1 year consensus target price of $5.33 for the company and are forecasting that the company will post ($0.31) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Xtant Medical Holdings an industry rank of 105 out of 265 based on the ratings given to its competitors.
Several analysts have recently weighed in on the company. Zacks Investment Research cut Xtant Medical Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, July 26th. HC Wainwright restated a “buy” rating on shares of Xtant Medical Holdings in a report on Thursday, August 4th.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/18/zacks-xtant-medical-holdings-inc-xtnt-given-consensus-recommendation-of-strong-buy-by-analysts.html
Shares of Xtant Medical Holdings (NASDAQ:XTNT) traded up 7.9900% during trading on Tuesday, hitting $1.0799. 48,610 shares of the stock were exchanged. Xtant Medical Holdings has a 12-month low of $0.93 and a 12-month high of $3.75. The stock’s market cap is $13.17 million. The stock’s 50 day moving average is $1.19 and its 200-day moving average is $1.78.
Xtant Medical Holdings Company Profile
Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Xtant Medical Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.